P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE

• Mattia D’agostino,
• Sara Bringhen,
• Nicola Giuliani,
• Elisabetta Antonioli,
• Renato Zambello,
• Francesco Cattel,
• Roberto Ria,
• Alessandro Allegra,
• Giovanna Leonardi,
• Angelo Belotti,
• Piero Galieni,
• Gloria Margiotta-Casaluci,
• Maria Cantonetti,
• Valentina Cotugno,
• Barbara Gamberi,
• Fabrizio Pane,
• Anna Marina Liberati,
• Patrizia Tosi,
• Maide Maria Cavalli,
• Donato Mannina,
• Giulia Benevolo,
• Silvia Mangiacavalli,
• Andrea Evangelista,
• Giovannino Ciccone,
• Mario Boccadoro,
• Benedetto Bruno,
• Alessandra Larocca

Affiliations

Mattia D’agostino

1 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Sara Bringhen

3 Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Department of Oncology, Torino, Italy

Nicola Giuliani

4 University of Parma, Hematology, Department of Medicine and Surgery, Parma, Italy

Elisabetta Antonioli

5 AOU Careggi, UO Ematologia, Firenze, Italy

Renato Zambello

6 Padua University, Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua, Italy

Francesco Cattel

7 A.O.U. Città della Salute e della Scienza di Torino, S.C. Farmacia Ospedaliera, Torino, Italy

Roberto Ria

8 University of Bari, Aldo Moro Medical School, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Bari, Italy

Alessandro Allegra

9 University of Messina, Azienda Ospedaliera-Universitaria G. Martino, Division of Hematology, Messina, Italy

Giovanna Leonardi

10 Azienda Ospedaliera Universitaria di Modena, U.O.C. Ematologia, Modena, Italy

Angelo Belotti

11 ASST Spedali Civili di Brescia, Department of Hematology, Brescia, Italy

Piero Galieni

12 Ospedale C. e G. Mazzoni, UOC Ematologia e Terapia cellulare, Ascoli Piceno, Italy

Gloria Margiotta-Casaluci

13 University of Eastern Piedmont, Division of Hematology, Department of Translational Medicine, Novara, Italy

Maria Cantonetti

14 Policlinico Tor Vergata (PTV) Foundation, Hematology Unit of Lymphoproliferative Disorders, Rome, Italy

Valentina Cotugno

7 A.O.U. Città della Salute e della Scienza di Torino, S.C. Farmacia Ospedaliera, Torino, Italy

Barbara Gamberi

15 Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy

Fabrizio Pane

16 University of Naples “Federico II”, Hematology Unit, Department of Clinical Medicine and Surgery, Naples, Italy

Anna Marina Liberati

17 AO Santa Maria di Terni/ Università degli studi di Perugia, S.C. di Oncoematologia, Terni/ Perugia, Italy

Patrizia Tosi

18 Ospedale di Rimini, UO Ematologia, Rimini, Italy

Maide Maria Cavalli

19 AULSS 6 Euganea, Osp. Camposampiero, UOSD Ematologia, Camposampiero (PD), Italy

Donato Mannina

20 Papardo Hospital, Oncology-Hematology Department, Messina, Italy

Giulia Benevolo

3 Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Department of Oncology, Torino, Italy

Silvia Mangiacavalli

21 IRCCS Fondazione Policlinico San Matteo, Division of Hematology, Pavia, Italy

Andrea Evangelista

22 A.O.U. Città della Salute e della Scienza di Torino and CPO Piemonte, Unit of Clinical Epidemiology, Torino, Italy

Giovannino Ciccone

22 A.O.U. Città della Salute e della Scienza di Torino and CPO Piemonte, Unit of Clinical Epidemiology, Torino, Italy

Mario Boccadoro

1 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Benedetto Bruno

1 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy

Alessandra Larocca

1 University of Torino, Division of Hematology, Department of Molecular Biotechnology and Health Sciences, Torino, Italy